Dolby Laboratories Inc (NYSE: DLB) is -16.57% lower on its value in year-to-date trading and has touched a low of $66.35 and a high of $90.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DLB stock was last observed hovering at around $73.55 in the last trading session, with the day’s loss setting it -1.65%.
Currently trading at $71.90, the stock is -2.12% and -6.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing -2.24% at the moment leaves the stock -11.86% off its SMA200. DLB registered -13.53% loss for a year compared to 6-month loss of -9.80%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -7.51% gain in the last 1 month and extending the period to 3 months gives it a -11.38%, and is 0.11% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.68% over the week and 2.17% over the month.
Dolby Laboratories Inc (DLB) has around 2246 employees, a market worth around $6.86B and $1.26B in sales. Current P/E ratio is 32.86 and Fwd P/E is 23.24. Profit margin for the company is 16.87%. Distance from 52-week low is 8.36% and -20.16% from its 52-week high. The company has generated returns on investments over the last 12 months (8.61%).
The EPS is expected to grow by 41.79% this year
587.0 institutions hold shares in Dolby Laboratories Inc (DLB), with institutional investors hold 95.25% of the company’s shares. The shares outstanding are 59.67M, and float is at 58.67M with Short Float at 1.34%. Institutions hold 93.84% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.6 million shares valued at $523.3 million. The investor’s holdings represent 6.9015 of the DLB Shares outstanding. As of 2024-06-30, the second largest holder is MORGAN STANLEY with 5.87 million shares valued at $465.04 million to account for 6.1332 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.79 million shares representing 6.0482 and valued at over $458.6 million, while KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.2176 of the shares totaling 3.08 million with a market value of $243.97 million.
Dolby Laboratories Inc (DLB) Insider Activity
The most recent transaction is an insider purchase by YEAMAN KEVIN J, the company’s President and CEO. SEC filings show that YEAMAN KEVIN J bought 3 shares of the company’s common stock on Jun 17 ’24 at a price of $78.15 per share for a total of $200.0. Following the purchase, the insider now owns 3.0 shares.
Dolby Laboratories Inc disclosed in a document filed with the SEC on May 28 ’24 that SHERMAN MARK ANDREW (EVP, Gen. Counsel & Secretary) sold a total of 2,283 shares of the company’s common stock. The trade occurred on May 28 ’24 and was made at $79.62 per share for $0.18 million. Following the transaction, the insider now directly holds 58325.0 shares of the DLB stock.
Still, SEC filings show that on Mar 01 ’24, Rollins Emily (Director) disposed off 1,000 shares at an average price of $80.88 for $80880.0. The insider now directly holds 7,493 shares of Dolby Laboratories Inc (DLB).
